Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Evidence & Practice Previous     Next

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders

Patrick Phillips Clinical research nurse and research associate, University of Sheffield, Sheffield, England and Member of the Cochrane Nursing Care Field

Summary statement

The mission of the Cochrane Nursing Care Field (CNCF) is to improve health outcomes through increasing the use of the Cochrane Library and supporting Cochrane’s role by providing an evidence base for nurses and healthcare professionals who deliver, lead or research nursing care. The CNCF produces Cochrane Corner columns, summaries of recent nursing-care-relevant Cochrane Reviews that are regularly published in collaborating nursing-related journals. Information on the processes CNCF has developed can be accessed at: cncf.cochrane.org/evidence-transfer-program-review-summaries. This is a Cochrane review summary of: Estcourt LJ, Desborough M, Brunskill SJ et al (2016) Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders. Cochrane Database of Systematic Reviews. Issue 3. CD009733. doi: 10.1002/14651858.CD009733.pub3.

Nursing Standard. 32, 10, 41-43. doi: 10.7748/ns.2017.e11006

@patphillips1867

Correspondence

p.phillips@sheffield.ac.uk

Conflict of interest

None declared

Received: 11 September 2017

Accepted: 11 September 2017

Want to read more?

Subscribe for unlimited access

Try 1 month’s access for just £1 and get:

Your subscription package includes:
  • Full access to nursingstandard.com and the Nursing Standard app
  • The monthly digital edition
  • RCNi Portfolio and interactive CPD quizzes
  • RCNi Learning with 200+ evidence-based modules
  • 10 articles a month from any other RCNi journal
Subscribe
Already subscribed? Log in

Alternatively, you can purchase access to this article for the next seven days. Buy now

Or